Clinical Trial Update: Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 study evaluating a transdermal prokinetic agent for bowel evacuation in persons with spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bowel
• Spinal Cord Injury

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Spinal Cord Injury, Neurogenic Bowel | EARLY_Phase 1 | Status: COMPLETED